Synergistic composition, useful for the treatment of ophthalmological dysfunction, e.g. allergic conjunctivitis, comprises mucopolysaccharide with heparin activity and viscosity regulator, preferably hyaluronic acid

摘要

New pharmaceutical compositions (I) comprise: (1) at least one mucopolysaccharide with heparin activity (A); (2) at least one viscosity regulator (B); and (3) optionally, further pharmaceutical auxiliaries (C).